Maze Therapeutics Applies Genetics Insights to Accelerate Drug Discovery Using AWS

“Biotech Blueprint allowed us to begin work almost immediately, rapidly deploying network and data architecture in days rather than months while ensuring that our analysis environment followed current best practices,” said Nolan Nichols, PhD, senior software engineer for Maze Therapeutics.